Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington ׳s disease

Author(s): Gupta S, Sharma B

Abstract

Huntington׳s disease (HD), a devastating neurodegenerative disorder, is characterized by weight loss, impairment of motor function, cognitive dysfunction, neuropsychiatric disturbances and striatal damage. Phosphodiesterase-1 (PDE1) has been implicated in various neurological diseases. Mitochondrial potassium channels in the brain take part in neuroprotection. This study has been structured to investigate the role of vinpocetine, a selective PDE1 inhibitor as well as nicorandil, selective ATP sensitive potassium (KATP) channel opener in 3-nitropropionic acid (3-NP) induced HD symptoms in rats. Systemic administration of 3-NP significantly, reduced body weight, impaired locomotion, grip strength and impaired cognition. 3-NP elicited marked oxidative stress in the brain (enhanced malondialdehyde-MDA, reduced glutathione-GSH content, superoxide dismutase-SOD and catalase-CAT), elevated brain acetylcholinesterase activity and inflammation (myeloperoxidase-MPO), with marked nitrosative stress (nitrite/nitrate) in the brain. 3-NP has also induced mitochondrial dysfunction (impaired mitochondrial NADH dehydrogenase-complex I, succinate dehydrogenase-complex II and cytochrome oxidase-complex IV) activities in the striatum of the rat. Tetrabenazine was used as a positive control. Treatment with vinpocetine, nicorandil and tetrabenazine ameliorated 3-NP induced reduction in body weight, impaired locomotion, grip strength and impaired cognition. Treatment with these drugs reduced brain striatum oxidative (MDA, GSH, SOD and CAT) and nitrosative (nitrite/nitrate) stress, acetylcholinesterase activity, inflammation and mitochondrial dysfunctions. These results indicate that vinpocetine, a selective PDE1 inhibitor and nicorandil, a KATP channel opener have attenuated 3-NP induced experimental HD. Hence, pharmacological modulation of PDE1 as well as KATP channels may be considered as potential research targets for mitigation of HD.

Similar Articles

Fish Oil Feeding Up-Regulates the Expression of 5-Aminolevulinate Synthase 2 mRNA in Rat Brain

Author(s): Haraguchi T, Yanaka N, Eguchi Y, Kudo T, Hirata A, et al.

Korean red ginseng ameliorates acute 3-nitropropionic acid-induced cochlear damage in mice

Author(s): Tian C, Kim YH, Kim YC, Park KT, Kim SW, et al.

Docosahexaenoic acid withstands the Aβ(25-35)-induced neurotoxicity in SH-SY5Y cells

Author(s): Hashimoto M, Katakura M, Hossain S, Rahman A, Shimada T, et al.

Determination of carbonyl content in oxidatively modified proteins

Author(s): Levine RL, Garland D, Oliver CN, Amici A, Climent I, et al.

Catalase in vitro

Author(s): Aebi H

Glutathione transferase from rat testis

Author(s): Guthenberg C, Alin P, Mannervik B

Assays of glutathione peroxidase

Author(s): Flohé L, Günzler WA

A new and rapid colorimetric determination of acetylcholinesterase activity

Author(s): Ellman GL, Courtney KD, Andres V, Feather-Stone RM

Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate

Author(s): Dalpiaz A, Filosa R, de Caprariis P, Conte G, BortolottiF, et al.

Biochemistry of dystrophic muscle

Author(s): Pennington RJ

Protein measurement with the Folin phenol reagent

Author(s): Lowry OH, Rosebrough NJ, Farr AL, Randall RJ

Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets

Author(s): Véricel E, Polette A, Bacot S, Calzada C, Lagarde M, et al.

Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics

Author(s): Dalle-Donne I, Scaloni A, Giustarini D,Cavarra E, Tell G, et al.

Protein oxidation and aging

Author(s): Stadtman ER

Reduced protein oxidation in Wistar rats supplemented with marine ω3 PUFAs

Author(s): Méndez L, Pazos M, Gallardo JM, Torres JL, Pérez-JiménezJ, et al.

Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats

Author(s): Deshpande SB, Hida H, Takei-Io N, Masuda T, Baba H, et al.

Glutathione synthesis

Author(s): Lu SC

Cholinergic neuronal defect without cell loss in Huntington’s disease

Author(s): Smith R, Chung H, Rundquist S, Maat-Schieman ML, Colgan L, et al.

Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats

Author(s): Al Mutairy A, Al Kadasah S, Elfaki I,Arshaduddin M, Malik D, et al.